Literature DB >> 29657063

Does previous transanal excision for early rectal cancer impair surgical outcomes and pathologic findings of completion total mesorectal excision? Results of a systematic review of the literature.

Y Eid1, A Alves2, J Lubrano2, B Menahem3.   

Abstract

BACKGROUND: Transanal excision (TAE) is increasingly used in the treatment of early rectal cancer because of lower rate of both postoperative complications and postsurgical functional disorders as compared with total mesorectal excision (TME)
OBJECTIVE: To compare in a meta-analysis surgical outcomes and pathologic findings between patients who underwent TAE followed by completion proctectomy with TME (TAE group) for early rectal cancer with unfavorable histology or incomplete resection, and those who underwent primary TME (TME group).
METHODS: The Medline and Cochrane Trials Register databases were searched for studies comparing short-term outcomes between patients who underwent TAE followed by completion TME versus primary TME. Studies published until December 2016 were included. The meta-analysis was performed using Review Manager 5.0 (Cochrane Collaboration, Oxford, UK).
RESULTS: Meta-analysis showed that completion TME after TAE was significantly associated with increased reintervention rate (OR=4.28; 95% CI, 1.10-16.76; P≤0.04) and incomplete mesorectal excision rate (OR=5.74; 95% CI, 2.24-14.75; P≤0.0003), as compared with primary TME. However there both abdominoperineal amputation and circumferential margin invasion rates were comparable between TAE and TME groups.
CONCLUSIONS: This meta-analysis suggests that previous TAE impaired significantly surgical outcomes and pathologic findings of completion TME as compared with primary TME. First transanal approach during completion TME might be evaluated in order to decrease technical difficulties.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Early rectal cancer; Rectal cancer; TEM-TAMIS-TME; TME; Transanal excision

Mesh:

Year:  2018        PMID: 29657063     DOI: 10.1016/j.jviscsurg.2018.03.008

Source DB:  PubMed          Journal:  J Visc Surg        ISSN: 1878-7886            Impact factor:   2.043


  4 in total

Review 1.  The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.

Authors:  R Zinicola; R Nascimbeni; R Cirocchi; G Gagliardi; N Cracco; M Giuffrida; G Pedrazzi; G A Binda
Journal:  Tech Coloproctol       Date:  2021-06-25       Impact factor: 3.781

2.  Completion total mesorectal excision following transanal endoscopic microsurgery does not compromise outcomes in patients with rectal cancer.

Authors:  Katarina Levic Souzani; Orhan Bulut; Tine Plato Kuhlmann; Ismail Gögenur; Thue Bisgaard
Journal:  Surg Endosc       Date:  2021-02-24       Impact factor: 4.584

3.  Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer.

Authors:  Javier Ernesto Barreras González; Haslen Cáceres Lavernia; Jorge Gerardo Pereira Fraga; Solvey Quesada Lemus
Journal:  Surg Endosc       Date:  2021-07-06       Impact factor: 4.584

4.  MRI cT1-2 rectal cancer staging accuracy: a population-based study.

Authors:  R Detering; S E van Oostendorp; V M Meyer; S van Dieren; A C R K Bos; J W T Dekker; O Reerink; J H T M van Waesberghe; C A M Marijnen; L M G Moons; R G H Beets-Tan; R Hompes; H L van Westreenen; P J Tanis; J B Tuynman
Journal:  Br J Surg       Date:  2020-04-16       Impact factor: 6.939

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.